CLINICAL TRIALS PROFILE FOR SEROSTIM
✉ Email this page to a colleague
All Clinical Trials for SEROSTIM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00071240 ↗ | Growth Hormone to Increase Immune Function in People With HIV | Completed | EMD Serono | Phase 2 | 2002-10-01 | Growth hormone plays an important role in the development of the immune system. Studies suggest that growth hormone may promote growth of the thymus, a gland responsible for the production of important immune cells called T cells. Since these cells are lost during the course of HIV infection, it is possible that growth hormone treatment could help restore the immune system. This study will determine whether the administration of growth hormone can increase the size and function of the thymus and cause an increase in the number of new T cells in the blood of people infected with HIV. Study hypothesis: Growth hormone treatment will enhance T cell production in HIV infected adults. |
| NCT00071240 ↗ | Growth Hormone to Increase Immune Function in People With HIV | Completed | National Center for Research Resources (NCRR) | Phase 2 | 2002-10-01 | Growth hormone plays an important role in the development of the immune system. Studies suggest that growth hormone may promote growth of the thymus, a gland responsible for the production of important immune cells called T cells. Since these cells are lost during the course of HIV infection, it is possible that growth hormone treatment could help restore the immune system. This study will determine whether the administration of growth hormone can increase the size and function of the thymus and cause an increase in the number of new T cells in the blood of people infected with HIV. Study hypothesis: Growth hormone treatment will enhance T cell production in HIV infected adults. |
| NCT00071240 ↗ | Growth Hormone to Increase Immune Function in People With HIV | Completed | The J. David Gladstone Institutes | Phase 2 | 2002-10-01 | Growth hormone plays an important role in the development of the immune system. Studies suggest that growth hormone may promote growth of the thymus, a gland responsible for the production of important immune cells called T cells. Since these cells are lost during the course of HIV infection, it is possible that growth hormone treatment could help restore the immune system. This study will determine whether the administration of growth hormone can increase the size and function of the thymus and cause an increase in the number of new T cells in the blood of people infected with HIV. Study hypothesis: Growth hormone treatment will enhance T cell production in HIV infected adults. |
| NCT00071240 ↗ | Growth Hormone to Increase Immune Function in People With HIV | Completed | University of California, San Francisco | Phase 2 | 2002-10-01 | Growth hormone plays an important role in the development of the immune system. Studies suggest that growth hormone may promote growth of the thymus, a gland responsible for the production of important immune cells called T cells. Since these cells are lost during the course of HIV infection, it is possible that growth hormone treatment could help restore the immune system. This study will determine whether the administration of growth hormone can increase the size and function of the thymus and cause an increase in the number of new T cells in the blood of people infected with HIV. Study hypothesis: Growth hormone treatment will enhance T cell production in HIV infected adults. |
| NCT00071240 ↗ | Growth Hormone to Increase Immune Function in People With HIV | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2002-10-01 | Growth hormone plays an important role in the development of the immune system. Studies suggest that growth hormone may promote growth of the thymus, a gland responsible for the production of important immune cells called T cells. Since these cells are lost during the course of HIV infection, it is possible that growth hormone treatment could help restore the immune system. This study will determine whether the administration of growth hormone can increase the size and function of the thymus and cause an increase in the number of new T cells in the blood of people infected with HIV. Study hypothesis: Growth hormone treatment will enhance T cell production in HIV infected adults. |
| NCT00082628 ↗ | Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients | Completed | EMD Serono | Phase 3 | 2004-05-28 | The primary objective of the study is to determine if Serostim® 4 mg administered daily for 12 weeks as treatment for the abnormal fat accumulation and distribution associated with HIV-associated Adipose Redistribution Syndrome (HARS) reduces Visceral Adipose Tissue (VAT, measured by CT scan) more effectively than placebo. |
| NCT00100698 ↗ | Physiologic Growth Hormone Effects in HIV Lipodystrophy | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A | 2004-01-01 | This study will investigate long-term, low-dose growth hormone administration in HIV-infected patients with reduced growth hormone (GH) secretion and increased visceral adiposity. We hypothesize that low-dose growth hormone will reduce visceral fat. Secondary endpoints will include measures of insulin-like growth factor-1 (IGF-1), glucose homeostasis, lipids, blood pressure,bone density, cardiovascular risk and safety parameters. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SEROSTIM
Condition Name
| Condition Name for SEROSTIM | |
| Intervention | Trials |
| HIV Infections | 5 |
| Human Immunodeficiency Virus Infections | 2 |
| Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) | 2 |
| HIV Wasting Syndrome | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for SEROSTIM
Trials by Country
Clinical Trial Progress for SEROSTIM
Clinical Trial Phase
Clinical Trial Sponsors for SEROSTIM
Sponsor Name
